Nigeria Pushes Gene Therapy Breakthrough Through Global Health Partnerships

Nigeria is intensifying efforts to advance gene therapy and advanced medical innovation as part of a broader strategy to strengthen healthcare delivery through international collaboration and scientific research.

The Federal Government says the move is aimed at expanding access to cutting-edge treatments such as CAR T-cell therapy, while also building local capacity for research-driven healthcare solutions.

Government Reaffirms Commitment to Health Innovation

The Minister of State for Health and Social Welfare, Dr. Iziaq Salako, reaffirmed the commitment of President Bola Ahmed Tinubu’s administration to translating emerging medical technologies into practical treatments for Nigerians.

He made this known in Abuja during a high-level engagement with a delegation from Caring Cross, a U.S.-based non-governmental organisation, alongside other international health partners and officials from the National Institute for Pharmaceutical Research and Development (NIPRD).

According to Salako, ongoing reforms under initiatives such as the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) and the Presidential Executive Order on the Pharmaceutical Sector are already improving health innovation, investment, and local production capacity.

Focus on Gene Therapy and CAR T-Cell Innovation

A key highlight of the discussions was the potential deployment of Chimeric Antigen Receptor (CAR) T-cell therapy, an advanced form of gene therapy used in treating cancers and blood-related diseases.

Salako noted that Africa has historically lagged behind in accessing such innovations due to limited infrastructure and technical capacity, but Nigeria is now positioning itself to change that narrative.

“We are working to ensure that science translates into impact, and that innovation directly improves lives,” he said.

He added that Nigeria is adopting an “all-of-government and all-of-Africa” approach to health innovation, aimed at strengthening regional collaboration and technology transfer.

Strengthening Local Research and Pharmaceutical Capacity

As part of efforts to harness indigenous knowledge and scientific research, the Federal Government has also established a National Phytomedicines Development Committee to explore Nigeria’s biodiversity for modern medical solutions.

Officials say the initiative is designed to integrate traditional knowledge systems with modern pharmaceutical research, potentially leading to locally developed treatments.

International Collaboration and Technology Transfer

The delegation from Caring Cross, led by Dr. Boro Dropulic, highlighted its work in developing viral vector technologies used in gene therapy and CAR-T cell treatments.

The organisation emphasized its goal of making advanced therapies more affordable and accessible, particularly for diseases such as sickle cell disease, leukemia, lymphoma, and multiple myeloma, which continue to affect a large number of patients in Africa.

Bridging the Healthcare Innovation Gap

Health experts say Nigeria’s renewed focus on gene therapy represents a significant step toward closing the gap between Africa and advanced medical systems globally.

Africa remains the only continent yet to fully scale CAR T-cell therapy in a structured healthcare framework, making the current initiative a potential turning point in medical innovation across the region.

Conclusion

With growing partnerships between Nigeria and global health institutions, the country is positioning itself to play a stronger role in advanced medical research, gene therapy development, and pharmaceutical innovation.

If successful, these efforts could reshape access to life-saving treatments and strengthen Nigeria’s position in global healthcare innovation.